Pfizer to seek COVID booster for healthy 5- to 11-year-olds.
In a small study, 140 youngsters who’d already gotten two shots were given a booster six months later, and researchers found the extra shot generally revved up their immune response. But a closer look at 30 of the children found a 36-fold increase in virus-fighting antibodies, levels high enough to fight the super-contagious omicron variant, Pfizer and its partner BioNTech said in a press release.
In the coming days, the companies plan to ask the U.S. Food and Drug Administration to authorize a booster for healthy 5- to 11-year-olds. They also plan to share the data with European and other regulators.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Pfizer to seek COVID booster for healthy 5- to 11-year-oldsNEW: Pfizer says it wants to expand its COVID-19 booster shots to healthy elementary-age kids.
続きを読む »
Pfizer to seek COVID booster for healthy 5- to 11-year-oldsPfizer said Thursday it wants to expand its COVID-19 booster shots to healthy children ages 5-11.
続きを読む »
Pfizer to seek COVID-19 booster for healthy 5- to 11-year-oldsPfizer said Thursday it wants to expand its COVID-19 booster shots to healthy elementary-age kids.
続きを読む »
Covid booster shot bolsters protection in 5-to-11-year-olds, Pfizer and BioNTech sayThe third shot appears to broaden the ability of the immune system to recognize variants such as omicron.
続きを読む »
Pfizer Says Covid-19 Booster in Children Ages 5 to 11 Sparked Immune Response Against OmicronA booster shot of the Pfizer-BioNTech Covid vaccine in children ages 5 to 11 significantly increased antibody levels against the Omicron variant as well as against the initial strain it was designed to fight, a late-stage study found.
続きを読む »
Pfizer aims to expand COVID booster shot to healthy kids ages 5 to 11Pfizer says new data shows healthy 5- to 11-year-olds could benefit from another kid-sized COVID-19 shot.
続きを読む »